PFIZER INC — Director's Dealing 2025

Mar 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2025-02-27

Reporting Person: DAMICO JENNIFER B. (SVP & Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-27	Common Stock	F	749.0000	$26.1000	Disposed	29761.0000	Direct
2025-03-04	Common Stock	A	5583.0000	$0.0000	Acquired	14350.0000	Direct
2025-03-04	Common Stock	S	2500.0000	$25.9300	Disposed	11850.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-04	Stock Appreciation Rights	$25.7500	A	47511.0000	Acquired	2030-03-04	Common Stock (47511.0000)	Direct

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

F2: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.